PeLeMed is a company specializing in the development of global innovative anticancer and antiviral drugs based on precision drug design and artificial intelligence drug development platform technology.

Based on our unique precision drug design technology and AI-applied high efficiency drug discovery platform, PeLeMed is focusing on discovery and development of precision therapies in refractory or incurable cancers and viral infectious diseases.